In OSCC, NLRP3 contributes to cancer cell proliferation, epithelial–mesenchymal transition (EMT), and enhanced metastatic potential by activating NF-κB and STAT3 signaling pathways [108]. This evidence concerns the gene NFKB1 and cancer.